E-LIB Suche - Ergebnisse für: Götte, Heiko

1

Simultaneous inference procedures for the comparison of mul..:

Ristl, Robin ; Götte, Heiko ; Schüler, Armin..
Statistical Methods in Medical Research. 33 (2024) 4 - p. 589-610 , 2024

Link: https://doi.org/10.1177/..

2

Going beyond probability of success: Opportunities for stat..:

Wiklund, Stig‐Johan ; Thorn, Katharine ; Götte, Heiko...
Pharmaceutical Statistics. 23 (2024) 3 - p. 429-438 , 2024

Link: https://doi.org/10.1002/..

3

Estimation of treatment effects in early-phase randomized c..:

Götte, Heiko ; Kirchner, Marietta ; Krisam, Johannes...
Journal of Biopharmaceutical Statistics. 34 (2023) 5 - p. 680-699 , 2023

Link: https://doi.org/10.1080/..

4

An adaptive design for early clinical development including..:

Götte, Heiko ; Kirchner, Marietta ; Krisam, Johannes...
Pharmaceutical Statistics. 21 (2022) 3 - p. 625-640 , 2022

Link: https://doi.org/10.1002/..

5

Robust group sequential designs for trials with survival en..:

Ghosh, Pranab ; Ristl, Robin ; König, Franz...
Biometrical Journal. 64 (2021) 2 - p. 343-360 , 2021

Link: https://doi.org/10.1002/..

6

Progression‐free survival in oncological clinical studies: ..:

Miltenberger, Robert ; Götte, Heiko ; Schüler, Armin.
Pharmaceutical Statistics. 20 (2021) 4 - p. 864-878 , 2021

Link: https://doi.org/10.1002/..

7

Optimal decision‐making in oncology development programs ba..:

Götte, Heiko ; Xiong, Junyuan ; Kirchner, Marietta..
Pharmaceutical Statistics. 19 (2020) 6 - p. 861-881 , 2020

Link: https://doi.org/10.1002/..

8

Optimal designs for phase II/III drug development programs ..:

Erdmann, Stella ; Kirchner, Marietta ; Götte, Heiko.
BMC Medical Research Methodology. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

9

Optimal Designs for Multi-Arm Phase II/III Drug Development..:

Preussler, Stella ; Kirchner, Marietta ; Götte, Heiko.
Statistics in Biopharmaceutical Research. 13 (2020) 1 - p. 71-81 , 2020

Link: https://doi.org/10.1080/..

10

Delayed treatment effects, treatment switching and heteroge..:

Ristl, Robin ; Ballarini, Nicolás M ; Götte, Heiko...
Pharmaceutical Statistics. 20 (2020) 1 - p. 129-145 , 2020

Link: https://doi.org/10.1002/..

11

Adjustment for exploratory cut‐off selection in randomized ..:

Götte, Heiko ; Kirchner, Marietta ; Kieser, Meinhard
Biometrical Journal. 62 (2019) 3 - p. 627-642 , 2019

Link: https://doi.org/10.1002/..

12

Handbook of Approximate Bayesian Computation. Edited by Sco..:

Götte, Heiko
Biometrical Journal. 61 (2019) 6 - p. 1601-1602 , 2019

Link: https://doi.org/10.1002/..

13

Optimal planning of phase II/III programs for clinical tria..:

Kieser, Meinhard ; Kirchner, Marietta ; Dölger, Eva.
Pharmaceutical Statistics. 17 (2018) 5 - p. 437-457 , 2018

Link: https://doi.org/10.1002/..

14

Simulation-based adjustment after exploratory biomarker sub..:

Götte, Heiko ; Kirchner, Marietta ; Sailer, Martin Oliver.
Statistics in Medicine. 36 (2017) 15 - p. 2378-2390 , 2017

Link: https://doi.org/10.1002/..

15

Probability of success for phase III after exploratory biom..:

Götte, Heiko ; Kirchner, Marietta ; Sailer, Martin Oliver
Pharmaceutical Statistics. 16 (2017) 3 - p. 178-191 , 2017

Link: https://doi.org/10.1002/..